Investors
OHMK Medical Technology invests $7 million in EndyMed Ltd
Israeli-company EndyMed Ltd has reached an agreement with the Chinese OHMK Medical Technology, which will acquire 47.93 million EndyMed shares (28.94 percent share capital and voting rights), for $7 million.
Enumeral Biomedical Holdings announces $21.5M funding round, Cerulean Group merger
Enumeral Biomedical Holdings announced that it had completed a merger between the company and its subsidiary, Cerulean Group, Inc. Along with the news of the merger, the company also announced the conclusion of its private placement financing, which raised $21.5 million.
British government-backed fund aids Destiny Pharma to raise £2.8M for XF-73 clinical drug trial
Destiny Pharma recently announced in a press release that it was able to raise £2.8 million to fund the clinical trial of a drug aimed to prevent post-surgical infections. The company's recent funding, which was led by British government-backed Angel CoFund, will aid
Hallspot reaches $1 million in third round of seed funding
Hallspot, a social network and mobile application aimed at establishing connections between college students and businesses, recently reached a million dollars in its third round of funding, according to the company.